Skip to main content

‘microfluidic devices’

Autoimmune drug shows promise in treating severe burns

Jan. 12, 2022—A severe burn injury is not static. Within 72 hours, partial thickness burns can progress, or convert, to full thickness burns, greatly increasing the risk of infection, incapacitating scarring, and even death. Preventing the conversion is one of the most challenging aspects of treating burns, and a trans-institutional team of researchers from Vanderbilt University Medical...

Read more


Enzyme helps build motor that drives neuron death

Aug. 6, 2018—A biochemistry instructor curious about an enzyme discovered in the damaged neurons of people with multiple sclerosis made a leap toward a potential cure for countless neurodegenerative ills. Vanderbilt University’s Amrita Pathak, working with Bruce D. Carter, biochemistry professor and associate director of the Vanderbilt Brain Institute, found that the enzyme histone deacetylase 1 (HDAC1),...

Read more